Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine only
Open Access
- 1 March 1996
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 100 (3) , 290-298
- https://doi.org/10.1016/s0002-9343(97)89487-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Phase II trial of recombinant interferon alfa‐2 in the treatment of primary systemic amyloidosisAmerican Journal of Hematology, 1993
- Phase II trial of α‐tocopherol (vitamin E) in the treatment of primary systemic amyloidosisAmerican Journal of Hematology, 1990
- Survival of patients with primary (AL) amyloidosisThe American Journal of Medicine, 1987
- Treatment of al amyloidosis with melphalan, prednisone, and colchicineArthritis & Rheumatism, 1986
- Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicineThe American Journal of Medicine, 1985
- Amyloidosis of the AL typeThe American Journal of Medicine, 1979
- A New Design for Randomized Clinical TrialsNew England Journal of Medicine, 1979
- The Successful Treatment of Primary Amyloidosis with Intermittent ChemotherapyAustralian and New Zealand Journal of Medicine, 1978
- AMYLOIDOSIS: REVIEW OP 236 CASESMedicine, 1975
- Patterns of Amyloidosis and Their Association with Plasma-Cell Dyscrasia, Monoclonal Immunoglobulins and Bence-Jones ProteinsNew England Journal of Medicine, 1974